Abstract

    Open Access Review Article Article ID: AHR-3-117

    Vitamin K: A potential Liver Cancer treatment way

    Sofi a Dahlberg and Ulf Schött*

    A review on different vitamin K1-3 effects on hepatocellular cancer and their tumour cell biology mechanism indicate possible synergistic treatment strategies. Monitoring of dysfunctional carboxylation of the vitamin K dependent coagulation factor II, with the commercial ELISA test PIVKA-II has been used as a hepatocellular cancer marker. Its relevance is also reviewed. Currently the PIVKA-II test has been withdrawn due to marketing reasons by Stago.

    Keywords: Vitamin K; Menaquinone; Hepatocellular cancer; Hepatitis; Cirrhosis; PIVKA-II

    Published on: Sep 26, 2017 Pages: 49-52

    Full Text PDF Full Text HTML DOI: 10.17352/ahr.000017
    CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat

    Indexing/Archiving

    Pinterest on AHR